Hilton Worldwide Holdings Inc. (0J5I)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 351.29 |
|---|---|
| 52-week range | 253.87 – 365.00 |
| Return, 1 month / 3 months | +13.4% / +10.3% |
| Return, 1 year / 3 years | +30.0% / +136.8% |
| Trend | Uptrend |
| RSI (14) | 68 |
| Volatility (1 year) | 23.1% |
| Worst drawdown (1 year) | -14.5% |
| Average daily value traded | 0.36M USD |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hilton Worldwide Holdings is a hospitality company that operates and franchises hotels and resorts under brands such as Hilton, Hampton, DoubleTree and Waldorf Astoria. It serves business and leisure travellers through owned, managed and franchised properties in cities and resort destinations around the world, and it also runs a loyalty programme for guests. The company is based in McLean, Virginia, in the United States.
Hilton Worldwide Holdings Inc. trades under the code 0J5I on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hilton Worldwide Holdings Inc. (0J5I) trades on the London Exchange in UK. It last closed at USD 351.29 on 23 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 1,107 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 30.0% and over the last three months it rose 10.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.7% | ||
| From 52-week high | -3.3% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 10.3% | ||
| 6-month return | 5.1% | ||
| 12-month return, skipping the last month | 14.6% | ||
| Stability (higher is calmer) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.5% | ||
| Liquidity | 43 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.36M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 5 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.9% |
|---|---|
| 1 month | +13.4% |
| 3 months | +10.3% |
| 6 months | +5.1% |
| 1 year | +30.0% |
| 3 years | +136.8% |
| 5 years | +151.3% |
Signals
| 50-day / 200-day average | 323.08 / 320.27 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 9.83 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Nov 2025 | USD 0.1500 |
| 28 Aug 2025 | USD 0.1500 |
| 22 May 2025 | USD 0.1500 |
| 20 Feb 2025 | USD 0.1500 |
| 15 Nov 2024 | USD 0.1500 |
| 23 Aug 2024 | USD 0.1500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.